Methicillin-resistant Staphylococcus aureus (MRSA) associated infection has become a worrisome issue worldwide. Glycopeptides are the backbone antibiotics for the treatment of MRSA infections. However, several reports have highlighted the limitations of vancomycin. Daptomycin is successfully used for the treatment of serious MRSA infections, however selection of resistant strains has been reported during daptomycin-monotherapy. This review will briefly discuss the available data on daptomycin/beta-lactam combination therapies for the treatment of MRSA infections.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
mrsa infections
12
methicillin-resistant staphylococcus
8
staphylococcus aureus
8
treatment mrsa
8
infections
4
aureus infections
4
infections role
4
role daptomycin/β-lactams
4
daptomycin/β-lactams combination
4
combination methicillin-resistant
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!